← Open Payments lookup

TROY STILES: Open Payments

NPI 1437122207 · BILLINGS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$75,536 in 116 payments from 11 companies in 2025. Trend: 2023 $54,746 · 2024 $24,712 · 2025 $75,536

Speaker / faculty: $64,442Travel & lodging: $4,754Consulting: $4,530Food & beverage: $1,699Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.58$50,068
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$24,829
Otsuka America Pharmaceutical, Inc.9$147
Janssen Pharmaceuticals, Inc5$109
Neurocrine BioSciences, Inc.3$81
Vanda Pharmaceuticals Inc.4$80
Alkermes, Inc.3$59
ABBVIE INC.2$55
Collegium Pharmaceutical, Inc.2$45
Lundbeck LLC2$36

Products named: AUSTEDO XR, CAPLYTA, UZEDY, REXULTI, INVEGA, INGREZZA, FANAPT, ARISTADA.

Industry payments across MT — which companies pay providers there.